Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Levrx is a private healthcare technology company focused on prescription drug navigation, pharmacy transparency, and digital engagement across the pharmacy benefit ecosystem. Its platform connects patients, providers, pharmacies, payers, employers, consultants, brokers, PBMs, and health plans to improve prescription workflows, reduce drug costs, and support better medication adherence and outcomes. The company markets products including the Levrx Member app and Levrx Practice app, and highlights Roxanne AI as the intelligence layer powering patient- and provider-facing recommendations. Levrx appears to operate as a commercial-stage digital health and pharmacy technology business rather than a therapeutics developer, with no disclosed drug pipeline, molecular targets, or clinical-stage assets. Recent positioning emphasizes specialty pharmacy navigation, transparent pharmacy pricing, and integrations that bring pharmacogenetic and marketplace data into the member experience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Levrx Technology.